BTEC
Principal Healthcare Innovators ETF
NASDAQ US Health Care Innovators TR USD
NAV as of
4 Week: 27.71 - 36.28
52 Week: 27.71 - 61.61
Latest Closing Price
31.49
Premium / Discount
0.13
Expense Ratio
0.42%
Investment Objective
The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index (the "index"). Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities in the Nasdaq US Benchmark Index that are small and medium capitalization U.S. healthcare companies.
Main Fund Characteristics
Performance
Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
---|---|---|---|
YTD | -33.41 | 3.03 | -11.04 |
1 Day | -0.06 | 0.00 | 0.00 |
1 Week | 2.64 | 6.98 | 0.38 |
1 Month | -11.27 | 18.99 | -0.59 |
3 Months | -13.75 | 25.43 | -0.54 |
6 Months | -36.78 | 32.35 | -1.14 |
1 Year | -42.04 | 35.90 | -1.17 |
2 Years | -27.54 | 47.52 | -0.58 |
3 Years | -1.53 | 60.00 | -0.03 |
5 Years | 18.65 | 70.85 | 0.26 |
10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 36.2654 | -11.2012 | 38.9183 | 52.5240 | -18.4398 |
Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 13.0000 | 90.0000 | 6.0000 | 9.0000 | 95.0000 |
Dividend Frequency
Lastest Dividend
Ex Date | Payment Date | Dividend Payout per unit |
---|---|---|
28/12/2021 | 02/01/2022 | 0.4532 |
16/12/2020 | 21/12/2020 | 0.2154 |
14/12/2017 | 19/12/2017 | 0.0415 |
Portfolio Data
Total Number of Holdings: 283
Number of Bond Holdings: 0
Number of Equity Holdings: 282
Total Market Value: 53,648,166
Portfolio Composition
Top 10 Holdings
% Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
---|---|---|---|---|---|
1 | Moderna Inc | 4.8242 | 60,736 | 2,617 | 7,953,379 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
Size | % of portfolio |
---|---|
Giant | 0.00 |
Large | 0.00 |
Medium | 25.77 |
Small | 44.74 |
Micro | 29.19 |
Equity Style Box Breakdown
0 | 0 | 0 | Large |
0 | 0 | 0 | Mid |
0 | 0 | 0 | Small |
Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
12.3533
Price/Book*
2.0146
Price/Sales*
1.8246
Price/Cash Flow*
11.3064
Dividend Yield*
0.0379
Growth Measures
Long-Term Earnings
21.6285
Historical Earnings
-19.0213
Sales Growth
0.2503
Cash-Flow Growth
-13.9685
Book-Value Growth
14.6094
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
Detail | Value |
---|---|
Average Effective Duration | 0 |
Average Effective Maturity (Years)* | 0 |
Average Credit Quality | 0 |
Average Weighted Coupon* | 0 |
Average Weighted Price* | 0 |
Bond Style Box Breakdown
0 | 0 | 0 | High | Quality |
0 | 0 | 0 | Med | |
0 | 0 | 0 | Low | |
Ltd | Mod | Ext | ||
Interest-Rate Sensitivity |
Credit Quality
Type | % Bonds |
---|---|
N.A |
Bond Sector
Bond Maturity
% Bonds | |
---|---|
N.A |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.